Document is current
Any future updates will be listed below
-
Authors
De Lillo, Antonella
Pathak, Gita A.
De Angelis, Flavio
Di Girolamo, Marco
Luigetti, Marco
Sabatelli, Mario
Perfetto, Federico
Frusconi, Sabrina
Manfellotto, Dario
Fuciarelli, Maria
Polimanti, Renato https://orcid.org/0000-0003-0745-6046
-
Funding
Funding for this research was provided by:
Pfizer
- License Information
-
More Information
Article History
Received: 7 October 2020
Accepted: 3 November 2020
First Online: 17 November 2020
Ethics approval and consent to participate
: This study was approved under the protocol 39/18 by the Comitato Etico Indipendente, Fondazione Policlinico Tor Vergata—Rome, Italy. Informed consent was obtained from each participant involved.
: Drs. Fuciarelli and Polimanti received research grants from Pfizer Inc. to conduct epigenetic studies of hATTR. The other authors reported no biomedical financial interests or potential conflicts of interest.
